全文获取类型
收费全文 | 49493篇 |
免费 | 6546篇 |
国内免费 | 141篇 |
专业分类
耳鼻咽喉 | 449篇 |
儿科学 | 1356篇 |
妇产科学 | 2321篇 |
基础医学 | 4134篇 |
口腔科学 | 1006篇 |
临床医学 | 17733篇 |
内科学 | 7715篇 |
皮肤病学 | 681篇 |
神经病学 | 3363篇 |
特种医学 | 1218篇 |
外国民族医学 | 1篇 |
外科学 | 5452篇 |
综合类 | 142篇 |
一般理论 | 14篇 |
预防医学 | 5082篇 |
眼科学 | 653篇 |
药学 | 2285篇 |
中国医学 | 93篇 |
肿瘤学 | 2482篇 |
出版年
2023年 | 1017篇 |
2022年 | 315篇 |
2021年 | 789篇 |
2020年 | 1052篇 |
2019年 | 736篇 |
2018年 | 1911篇 |
2017年 | 2042篇 |
2016年 | 2162篇 |
2015年 | 2309篇 |
2014年 | 2415篇 |
2013年 | 3100篇 |
2012年 | 2299篇 |
2011年 | 2740篇 |
2010年 | 2074篇 |
2009年 | 2142篇 |
2008年 | 2020篇 |
2007年 | 2099篇 |
2006年 | 1928篇 |
2005年 | 1859篇 |
2004年 | 1762篇 |
2003年 | 1648篇 |
2002年 | 1503篇 |
2001年 | 1142篇 |
2000年 | 969篇 |
1999年 | 1012篇 |
1998年 | 786篇 |
1997年 | 873篇 |
1996年 | 801篇 |
1995年 | 714篇 |
1994年 | 520篇 |
1993年 | 438篇 |
1992年 | 617篇 |
1991年 | 569篇 |
1990年 | 596篇 |
1989年 | 517篇 |
1988年 | 456篇 |
1987年 | 440篇 |
1986年 | 449篇 |
1985年 | 468篇 |
1984年 | 361篇 |
1983年 | 312篇 |
1982年 | 216篇 |
1981年 | 213篇 |
1979年 | 328篇 |
1978年 | 229篇 |
1977年 | 211篇 |
1975年 | 199篇 |
1974年 | 237篇 |
1973年 | 228篇 |
1972年 | 294篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
103.
104.
105.
Chronic intestinal pseudo-obstruction: manifestations, natural history and management 总被引:2,自引:0,他引:2
v. stanghellini r. f. cogliandro r. de giorgio g. barbara b. salvioli & r. corinaldesi 《Neurogastroenterology and motility》2007,19(6):440-452
Chronic intestinal pseudo-obstruction (CIPO) is a rare pathological condition characterized by a marked derangement of gut propulsive motility mimicking mechanical obstruction, in the absence of any lesion occluding the gut lumen. This disease is often associated with a disabling and potentially life-threatening complications and is still too often unrecognized even in referral centres. As a result, patients receive neither appropriate care nor recognition of their severe health condition. Medical and surgical therapies are often unsatisfactory and long-term outcome turns out to be poor in the vast majority of cases. This article focuses on the main clinical features, the management and long-term outcome of patients affected by CIPO, with particular emphasis on those aspects which remain a matter of debate. 相似文献
106.
P. G?r?g 《International journal of experimental pathology》1991,72(2):227-237
The ability of native and oxidized lipids and lipoproteins to stimulate production of reactive oxygen species (ROS; superoxide and hydrogen peroxide) by human blood monocytes has been studied in vitro. Neither native human low density lipoprotein (LDL), ''altered'' LDL (oxidized either by lipoxygenase, activated human monocytes or air) nor oxidized cholesterol had any significant effect on ROS production of monocytes. However, different oxidation products of a lipid emulsion (Lipofundin; largely consisting of linoleic acid oxidized either by lipoxygenase, Fe3+ or ultraviolet irradiation) greatly enhanced ROS production of monocytes. A hypothesis that activation of circulating leucocytes by oxidized fatty acids may generate oxidized plasma LDL, was tested in rabbits. Characteristics of LDL, separated from rabbit plasma 6 h after intravenous injection of an oxidized lipid emulsion, was compared to that of LDL isolated before the lipid treatment. Post-treatment LDL-fraction of plasma had increased lipid peroxide content and compared to the pretreatment LDL, caused a threefold increase in the incorporation of cholesterol into cultured (rat aortic) endothelial cells. The observed intense and lasting stimulation of monocytes by oxidized polyunsaturated fatty acids in vitro, and the generation of ''altered'' LDL by these oxidized lipids in vivo suggests a mechanism by which atherogenic oxidized LDL could form in the circulation. 相似文献
107.
108.
He Li Lawrence M Schopfer Florian Nachon Marie-Thérèse Froment Patrick Masson Oksana Lockridge 《Toxicological sciences》2007,100(1):136-145
Some organophosphorus compounds are toxic because they inhibit acetylcholinesterase (AChE) by phosphylation of the active site serine, forming a stable conjugate: Ser-O-P(O)-(Y)-(XR) (where X can be O, N, or S and Y can be methyl, OR, or SR). The inhibited enzyme can undergo an aging process, during which the X-R moiety is dealkylated by breaking either the P-X or the X-R bond depending on the specific compound, leading to a nonreactivatable enzyme. Aging mechanisms have been studied primarily using AChE. However, some recent studies have indicated that organophosphate-inhibited butyrylcholinesterase (BChE) may age through an alternative pathway. Our work utilized matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry to study the aging mechanism of human BChE inhibited by dichlorvos, echothiophate, diisopropylfluorophosphate (DFP), isomalathion, soman, sarin, cyclohexyl sarin, VX, and VR. Inhibited BChE was aged in the presence of H2O18 to allow incorporation of (18)O, if cleavage was at the P-X bond. Tryptic-peptide organophosphate conjugates were identified through peptide mass mapping. Our results showed no aging of VX- and VR-treated BChE at 25 degrees C, pH 7.0. However, BChE inhibited by dichlorvos, echothiophate, DFP, soman, sarin, and cyclohexyl sarin aged exclusively through O-C bond cleavage, i.e., the classical X-R scission pathway. In contrast, isomalathion aged through both X-R and P-X pathways; the main aged product resulted from P-S bond cleavage and a minor product resulted from O-C and/or S-C bond cleavage. 相似文献
109.
110.